While breast cancer pathogenesis predominantly depends on HER2 overexpression caused by gene amplification, HER2-associated lung tumors may exhibit either HER2 overexpression or somatic mutations [24,25]. This evidence concerns the gene ERBB2 and breast carcinoma.